Post-CABG Surgery Management
All patients must receive aspirin within 6 hours postoperatively (100-325 mg daily) and continue indefinitely, along with high-dose statin therapy, unless contraindicated. 1
Core Pharmacotherapy (Class I Recommendations)
Antiplatelet Therapy
- Aspirin: Initiate 100-325 mg daily within 6 hours post-surgery if not started preoperatively, then continue indefinitely 1
- Critical for saphenous vein graft (SVG) patency, particularly in the first postoperative year
- Doses ranging from 100 mg daily to 325 mg three times daily are efficacious
- Clopidogrel 75 mg daily is a reasonable alternative only if aspirin intolerant or allergic 1
Lipid Management
- All patients require statin therapy unless contraindicated 1
- Target LDL cholesterol <100 mg/dL with at least 30% reduction from baseline 1
- For very high-risk patients, target LDL <70 mg/dL is reasonable 1
- For urgent/emergency CABG patients not on statins: initiate high-dose statin therapy immediately 1
- Never discontinue statins before or after CABG in patients without adverse reactions 1
Beta-Blockers
- Continue beta-blockers postoperatively in patients already receiving them preoperatively 1
- IV administration reasonable in stable patients unable to take oral medications 1
- Caution: Effectiveness uncertain in patients with LVEF <30% 1
ACE Inhibitors/ARBs
Reinstitute postoperatively once patient is stable if given preoperatively 1
Mandatory initiation (Class I) for patients NOT previously on ACE-I/ARBs who have: 1
- LVEF ≤40%
- Hypertension
- Diabetes mellitus
- Chronic kidney disease
Reasonable to initiate (Class IIa) in all low-risk CABG patients (normal LVEF, well-controlled risk factors) 1
Critical Safety Considerations:
- Do NOT initiate if systolic BP <100 mmHg 1
- Monitor for vasoplegia syndrome (severe hypotension after cardiopulmonary bypass) 1
- Risk of postoperative renal dysfunction 1
- Safety of initiating before hospital discharge not well established 1
Antiplatelet Drug Timing Around CABG
Preoperative Management
- Aspirin: Continue perioperatively; associated with reduced mortality without increased bleeding risk 2
- Clopidogrel: Stop ≥5 days before surgery (50% higher major bleeding risk if continued) 2
- Prasugrel: Stop 7 days before surgery (13.4% vs 3.2% CABG-related bleeding with clopidogrel) 1
- Ticagrelor: Stop 3-5 days before surgery (similar bleeding rates to clopidogrel when stopped appropriately) 1, 2
Postoperative Resumption
Resume aspirin within 24 hours post-CABG 2. The ATACAS trial demonstrated no increased bleeding risk with early aspirin resumption and maintained cardiovascular protection 2.
Essential Non-Pharmacologic Interventions
Cardiac Rehabilitation
Enroll all patients in cardiac rehabilitation program 3. This is a cornerstone of recovery that improves both physiological recovery and emotional resilience 4.
Lifestyle Modifications
- Smoking cessation: Mandatory counseling and support 5
- Aggressive hypertension management 5
- Structured exercise and dietary counseling through cardiac rehabilitation 4
Psychological Screening
Screen and treat for depression 3. Psychological well-being significantly impacts long-term outcomes and quality of life 4.
Monitoring for Complications
Early Recognition Priorities
Post-CABG complications span multiple organ systems and require vigilant monitoring 6, 7:
Cardiac: Atrial fibrillation (most common arrhythmia), graft failure, pericardial effusion/tamponade Neurological: Stroke, delirium, critical illness polyneuropathy 8 Pulmonary: Pneumonia, pleural effusion, pulmonary hypertension Renal: Acute kidney injury (especially with ACE-I/ARB use) Infectious: Sternal wound infections (requires aggressive management with debridement, antibiotics, possible flap reconstruction) 8 Metabolic: Electrolyte disturbances, glycemic control
High-Risk Patient Factors
Consistently identified risk factors across complications include 6:
- Advanced age
- Diabetes mellitus
- Renal dysfunction
- Prolonged cardiopulmonary bypass time
- Prior stroke
- COPD
- Impaired left ventricular function
Up to 14% of patients present to emergency departments within 30 days of discharge with postoperative complications 7. Early surgical consultation is imperative for any concerning findings.
Long-Term Follow-Up
Primary care practitioners play a pivotal role in delivering long-term secondary prevention 4. Recent evidence demonstrates that increasing the number of guideline-directed medical therapy (GDMT) medication classes at discharge is strongly associated with reduced mortality (HR 0.64, p<0.001), with the strongest associations for SGLT2 inhibitors (HR 0.39) and ACE-I/ARBs (HR 0.61) 9.
Despite surgical success, patients remain at risk for ischemic events in subsequent years, mandating aggressive secondary prevention 5. Optimizing graft patency and managing comorbid conditions are essential for achieving the highest level of physical health and quality of life following CABG 5.